Respiratory viruses diagnosed in the prospective cohort (N = 360 subjects)
| Respiratory virus . | Count . | Developed LRTI (%) . |
|---|---|---|
| Adenovirus | 22 | 7 (31.8) |
| Coronavirus 229E | 26 | 2 (7.7) |
| Coronavirus OC43 | 44 | 5 (11.4) |
| Coronavirus type HKU1 | 33 | 1 (3.0) |
| Coronavirus type NL63 | 25 | 3 (12.0) |
| Human metapneumovirus | 29 | 8 (27.6) |
| Human rhinovirus/enterovirus | 250 | 28 (11.2) |
| Influenza virus type A | 19 | 2 (10.5) |
| Influenza virus type B | 16 | 3 (18.8) |
| Parainfluenza virus type 1 | 12 | 2 (16.7) |
| Parainfluenza virus type 2 | 1 | 0 (0.0) |
| Parainfluenza virus type 3 | 47 | 4 (8.5) |
| Parainfluenza virus type 4 | 6 | 1 (16.7) |
| Respiratory syncytial virus | 64 | 18 (28.1) |
| Total | 594 | 84 (14.1) |
| Respiratory virus . | Count . | Developed LRTI (%) . |
|---|---|---|
| Adenovirus | 22 | 7 (31.8) |
| Coronavirus 229E | 26 | 2 (7.7) |
| Coronavirus OC43 | 44 | 5 (11.4) |
| Coronavirus type HKU1 | 33 | 1 (3.0) |
| Coronavirus type NL63 | 25 | 3 (12.0) |
| Human metapneumovirus | 29 | 8 (27.6) |
| Human rhinovirus/enterovirus | 250 | 28 (11.2) |
| Influenza virus type A | 19 | 2 (10.5) |
| Influenza virus type B | 16 | 3 (18.8) |
| Parainfluenza virus type 1 | 12 | 2 (16.7) |
| Parainfluenza virus type 2 | 1 | 0 (0.0) |
| Parainfluenza virus type 3 | 47 | 4 (8.5) |
| Parainfluenza virus type 4 | 6 | 1 (16.7) |
| Respiratory syncytial virus | 64 | 18 (28.1) |
| Total | 594 | 84 (14.1) |